[go: up one dir, main page]

DK1962960T3 - Fremgangsmåde til mikornisering - Google Patents

Fremgangsmåde til mikornisering

Info

Publication number
DK1962960T3
DK1962960T3 DK06830454.2T DK06830454T DK1962960T3 DK 1962960 T3 DK1962960 T3 DK 1962960T3 DK 06830454 T DK06830454 T DK 06830454T DK 1962960 T3 DK1962960 T3 DK 1962960T3
Authority
DK
Denmark
Prior art keywords
micornization
Prior art date
Application number
DK06830454.2T
Other languages
English (en)
Inventor
Nobert Rasenack
Michael Walz
Hagen Graebner
Michael Trunk
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1962960T3 publication Critical patent/DK1962960T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DK06830454.2T 2005-12-14 2006-12-07 Fremgangsmåde til mikornisering DK1962960T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005059602A DE102005059602A1 (de) 2005-12-14 2005-12-14 Verfahren zur Mikronisierung
PCT/EP2006/069450 WO2007068655A1 (de) 2005-12-14 2006-12-07 Verfahren zur mikronisierung

Publications (1)

Publication Number Publication Date
DK1962960T3 true DK1962960T3 (da) 2013-08-26

Family

ID=37712458

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10180211.4T DK2298415T3 (da) 2005-12-14 2006-12-07 Tiotropiumbromid-mikronisat
DK06830454.2T DK1962960T3 (da) 2005-12-14 2006-12-07 Fremgangsmåde til mikornisering

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10180211.4T DK2298415T3 (da) 2005-12-14 2006-12-07 Tiotropiumbromid-mikronisat

Country Status (9)

Country Link
US (1) US9156835B2 (da)
EP (2) EP1962960B1 (da)
JP (1) JP5522940B2 (da)
CA (1) CA2631949C (da)
DE (1) DE102005059602A1 (da)
DK (2) DK2298415T3 (da)
ES (2) ES2426012T3 (da)
PL (2) PL2298415T3 (da)
WO (1) WO2007068655A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2881376B2 (ja) 1994-03-07 1999-04-12 株式会社住友金属エレクトロデバイス グリーンシート積層方法及び装置
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
US10500232B2 (en) 2013-08-26 2019-12-10 The J. David Gladstone Ins., a testamentary trust established under the Will of J. David Gladstone Small molecule cellular reprogramming to generate neuronal cells
CN114828828A (zh) * 2019-11-06 2022-07-29 曼金德公司 氯法齐明的组合物,含它们的组合,它们的制备方法,含它们的用途和治疗方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
GB2178965B (en) 1985-07-30 1988-08-03 Glaxo Group Ltd Devices for administering medicaments to patients
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE4142711A1 (de) * 1991-12-21 1993-06-24 Hoechst Ag Verfahren zur herstellung von kristallinen natriumdisilikaten
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
AP1572A (en) * 2000-10-12 2006-02-13 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and use thereof in the production of a medicament.
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DE10064816A1 (de) 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
DE10141376A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7250426B2 (en) * 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
CA2519682A1 (en) * 2003-03-28 2004-10-07 Altana Pharma Ag Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
US7497903B2 (en) * 2004-09-28 2009-03-03 Advanced Minerals Corporation Micronized perlite filler product

Also Published As

Publication number Publication date
ES2426012T3 (es) 2013-10-18
US20100215590A1 (en) 2010-08-26
CA2631949C (en) 2014-05-27
CA2631949A1 (en) 2007-06-21
JP5522940B2 (ja) 2014-06-18
PL1962960T3 (pl) 2013-10-31
EP2298415A1 (de) 2011-03-23
DE102005059602A1 (de) 2007-06-21
EP1962960A1 (de) 2008-09-03
DK2298415T3 (da) 2013-08-26
JP2009519295A (ja) 2009-05-14
EP2298415B1 (de) 2013-06-12
PL2298415T3 (pl) 2013-11-29
US9156835B2 (en) 2015-10-13
ES2427273T3 (es) 2013-10-29
EP1962960B1 (de) 2013-05-29
WO2007068655A1 (de) 2007-06-21

Similar Documents

Publication Publication Date Title
CY2022001I2 (el) Παραγωγα του uk-2a
DK3136030T3 (da) Fremgangsmåde til lyofilisering
LT2351578T (lt) Vakcinų gavimo būdas
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
DK1720866T3 (da) Fremgangsmåde
DK1879623T3 (da) Genterapi til rygmarvssygdomme
ZA200805297B (en) Method of using ß-hydroxy-ß-methylbutyrate
FI20055581L (fi) Erotusmenetelmä
ITMO20050067A1 (it) Mezzi di illuminazione e metodo per ottenere mezzi di illuminazione.
DK2004794T3 (da) Fremgangsmåde til mæskning
BRPI0716528A2 (pt) mÉtodo de estabilizaÇço
BRPI0718145A2 (pt) Método de micronização
DE602006002419D1 (de) Eintauchverfahren
EP1732707A4 (en) ACTIVATION METHOD
FI20065363A0 (fi) Erotusmenetelmä
EP1910272A4 (en) Renin Inhibitors
DK1962960T3 (da) Fremgangsmåde til mikornisering
DK1955066T3 (da) Membran-assay-fremgangsmåde
FR2877833B1 (fr) Correcteur de lordoses
FI20055133A0 (fi) Iskulaite
FI20050681L (fi) Paikoitusmenetelmä
FI20061136A0 (fi) Seulontamenetelmä
FI20050571A0 (fi) Käyttömenetelmä
ITMO20050232A1 (it) Metodo
SE0402212D0 (sv) Method